Meta Platforms pulled back slightly from last week's $669 peak to close Tuesday at $661, but the positioning picture heading into July 22 earnings remains firmly bullish — with options, borrow, and analyst consensus all pointing the same direction.
The options market has not flinched. The put/call ratio ticked down to 0.43 on Tuesday, essentially matching its 52-week low and running nearly one standard deviation below the 20-day average of 0.45. Call buyers who led the price recovery from the late-June $542 trough are still adding, not hedging. The borrow market tells an equally unexciting story for bears: cost to borrow has fallen 30% over the past week to just 0.27%, and availability is effectively uncapped, with over two billion shares available to lend. Short interest edged up roughly 15% on the week in share terms but, at 1.6% of the free float, remains well inside territory that would constitute meaningful bearish conviction. The lending market offers bears no friction whatsoever — this is a stock where the short side is easy to put on and apparently not being put on at scale.
The Street's overall posture is bullish, though a few shops trimmed targets ahead of the print. UBS cut to $766 from $865 on Monday, maintaining its Buy, while Citizens edged its target to $800 from $825 the prior week — both moves reflecting some earnings-risk caution rather than a change in view. The consensus mean sits at $826, implying roughly 25% upside from Tuesday's close, a gap that has only compressed modestly despite the 16% one-month rally. Bulls emphasise AI-driven ad-targeting improvements and the $50-billion Louisiana data center expansion announced last week as tangible evidence that infrastructure spend is translating into durable revenue architecture. Bears continue to flag regulatory pressure on the data-monetisation model and the persistent drag from Reality Labs. Valuation has re-rated on the move: the trailing P/E is 16.3x, down nearly two full turns over thirty days as earnings estimates have risen faster than price — an earnings yield expansion that gives the bull case room to breathe.
The institutional picture offers one noteworthy data point from recent filings: Capital Research and Management added 6.7 million shares in the quarter to June 30, and JPMorgan Asset Management added 4 million over the same period. Zuckerberg's 13.5% stake remains unchanged. On the insider side, COO Javier Olivan sold roughly $2.1 million across multiple tranches on July 6 at prices around $600-603 — routine plan-based activity at levels now below the current quote, and flagged at low significance scores. Net insider activity over the past ninety days is marginally positive in share terms.
History adds a note of caution to the otherwise bullish setup. The Q1 print on April 29 produced a one-day drop of 8.9% that extended to nearly 9% over the following week — a stark contrast to the Q4 release in late May, which generated a 3.7% gain. The two-event sample is too thin to model, but it does underscore that a wide analyst consensus gap and call-heavy options positioning are not sufficient insulation against a miss. After the April drop, the stock recovered to new highs — but that recovery took weeks, not days.
With earnings seven days out, the question is less about whether Meta's AI ad story is intact — the institutional additions and options positioning suggest the market believes it is — and more about whether Q2 revenue guidance is strong enough to begin closing that remaining 25% discount to the Street's mean target.
See the live data behind this article on ORTEX.
Open META on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
